Leaps by Bayer
Biotech Investor · 4 portfolio companies
Portfolio
4
Combined Value
$413.9M
Focus Areas
6
Top Stage
Phase 1
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Century Therapeutics | $413.9M |
| Indapta Therapeutics | — |
| Khloris Biosciences | — |
| Garuda Therapeutics | — |